Grace Therapeutics, Inc. (GRCE) Stock Analysis

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

• Price: $4.12
• Market Cap: $61.76M
• EPS: $-0.31
• 52-Week High: $4.30
• 52-Week Low: $1.75

About Grace Therapeutics, Inc.

Grace Therapeutics, Inc., headquartered in Princeton, New Jersey, is a forward-thinking pharmaceutical company dedicated to the development of innovative therapies specifically for rare and orphan diseases. By harnessing advanced research methodologies and deep clinical expertise, the company is focused on addressing critical unmet medical needs in Canada and beyond. With a robust pipeline of specialized products, Grace Therapeutics positions itself strategically within the rare disease thera...

GNG Research provides proprietary Safety Scores, Quality Scores, Fair Value estimates, and Valuation Ratings for Grace Therapeutics, Inc. and 4,500+ other companies. Learn more about GNG Pro.

Frequently Asked Questions

Does GRCE pay dividends?

Grace Therapeutics, Inc. (GRCE) does not currently pay a regular dividend.

What is GRCE's market cap?

Grace Therapeutics, Inc. (GRCE) has a market capitalization of $61.76M with a current stock price of $4.12.